Boyd Lund is Director, Chemistry, Manufacturing and Controls (CMC) for Cardinal Health Regulatory Sciences.
Lund manages a team of CMC consultants who are responsible for the preparation of investigational, registration and post-marketing dossiers; CMC regulatory affairs; CMC quality assurance; Good Manufacturing Practices (GMP) audits and Good Laboratory Practices (GLP) audits. He provides scientific and regulatory consulting services for activities associated with CMC pharmaceutical product development and performs global compliance audits.
Lund has more than 24 years of experience in the pharmaceutical industry and specializes in contract manufacturing and testing, specialty pharmaceuticals and regulatory consulting. Prior to joining Cardinal Health in 2004, Lund worked in quality assurance at Oread Laboratories, where he held varying positions up to directorship. He was head of quality assurance/quality control and outsourcing at CyDex, Inc., and an analytical development group leader at Quintiles. Lund also has expertise in outsourcing management, pharmaceutical business development and facility design reviews.
Lund received a bachelor’s degree in cellular biology from the University of Kansas.